IL6 and Alzheimer disease: All components of the classical IL-6 signaling pathway (IL-6, IL-6R, and the signal-transducing component gp130) are detectable in the brain, with evidence of altered cortical immunoreactivity of the functional IL-6 receptor complex in AD [40].